When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
The musician-turned-biotech-founder waiting to fundraise
Related Posts
We’re feeling cynical about xAI’s big deal with Anthropic
On the latest episode of the Equity podcast, we discussed what xAI’s deal with Anthropic might mean for…
What LG and NVIDIA’s talks reveal about the future of physical AI
LG is currently engaged in exploratory discussions with NVIDIA concerning physical AI, data centres, and mobility. Following a…
Sierra raises $950M as the race to own enterprise AI gets serious
The raise gives Sierra more than $1 billion to work with — capital the company says it will…
